Oncopeptides AB (publ) (ONPPF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 36.29 Million SEK | 334.77% |
| 2022 | 8.34 Million SEK | -87.19% |
| 2021 | 65.17 Million SEK | 552.5% |
| 2020 | -14.4 Million SEK | -217.25% |
| 2019 | -4.54 Million SEK | -1215.94% |
| 2018 | -345 Thousand SEK | -27.31% |
| 2017 | -271 Thousand SEK | -1025.7% |
| 2016 | -24.07 Thousand SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 7.2 Million SEK | 50.64% |
| 2024 Q1 | 4.78 Million SEK | 5.03% |
| 2023 Q2 | 25.92 Million SEK | 2229.65% |
| 2023 Q3 | 909 Thousand SEK | -96.49% |
| 2023 Q1 | 1.11 Million SEK | 100.9% |
| 2023 Q4 | 4.55 Million SEK | 401.21% |
| 2023 FY | 36.29 Million SEK | 334.77% |
| 2022 Q1 | - SEK | 100.0% |
| 2022 FY | 8.34 Million SEK | -87.19% |
| 2022 Q2 | 8.75 Million SEK | 0.0% |
| 2022 Q4 | 554 Thousand SEK | 157.83% |
| 2022 Q3 | -958 Thousand SEK | -110.94% |
| 2021 Q4 | -40.08 Million SEK | -276.73% |
| 2021 FY | 65.17 Million SEK | 552.5% |
| 2021 Q1 | 19.02 Million SEK | 0.0% |
| 2021 Q2 | 63.55 Million SEK | 234.01% |
| 2021 Q3 | 22.68 Million SEK | -64.31% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 Q3 | - SEK | 0.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2020 FY | -14.4 Million SEK | -217.25% |
| 2020 Q2 | - SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 FY | -4.54 Million SEK | -1215.94% |
| 2019 Q4 | - SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 FY | -345 Thousand SEK | -27.31% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 FY | -271 Thousand SEK | -1025.7% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 FY | -24.07 Thousand SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 9.61 Million USD | -277.682% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 29314.252% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 69.524% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 11460.94% |
| Qrons Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | -135.328% |
| CSL Limited | 7.56 Billion USD | 99.52% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -210.089% |
| Arch Therapeutics, Inc. | -2439.00 USD | 1488373.883% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -20459.017% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 240.705% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 75317.058% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -25735.587% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -142.009% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -1170080.529% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -270.625% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -55126.083% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 106392.826% |
| Mesoblast Limited | -35.16 Million USD | 203.216% |
| Marizyme, Inc. | 457.7 Thousand USD | -7830.706% |
| Genus plc | 178.7 Million USD | 79.687% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 83.508% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -58234.137% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -8749.853% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 330090.909% |
| ContraFect Corporation | -154 Thousand USD | 23670.779% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 72698.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -47188.337% |
| IMV Inc. | -962.29 Thousand USD | 3872.116% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 9467.46% |
| MultiCell Technologies, Inc. | 49.32 USD | -73598845.661% |
| ONE Bio Corp. | 20.12 Million USD | -80.364% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 9.85% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -74131.084% |
| Q BioMed Inc. | -8988.00 USD | 403960.703% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -28.469% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 235441.027% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 18.168% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 3279.738% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -51755.714% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 733116.963% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 37324.017% |
| GB Sciences, Inc. | -624.00 USD | 5817247.436% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 42294.402% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 17451542.308% |
| Enzolytics Inc. | 30.7 Thousand USD | -118106.982% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -7424.154% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 96.725% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 7155.062% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -5779.485% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 91.137% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 409980.307% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 43390.916% |
| Kadimastem Ltd | -630.13 Thousand USD | 5860.484% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -3574.059% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 306808.914% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -20459.017% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -2574.663% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 125268.966% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -7965.674% |
| SYBLEU INC | 11.69 Thousand USD | -310253.967% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -687.739% |
| Bioxytran, Inc. | -8285.00 USD | 438229.149% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 9831.635% |
| Neutra Corp. | 14.33 Thousand USD | -253119.393% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 44367.073% |
| PureTech Health plc | -1.6 Million USD | 2364.442% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 3725.419% |
| IXICO plc | 3.27 Million USD | -1010.061% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 5330.403% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 2126.745% |
| CSL Limited | 7.7 Billion USD | 99.529% |
| Cellectis S.A. | 18 Thousand USD | -201561.111% |